Related Experiment Video
Updated: May 8, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Emerging families of biomarkers for coronary artery disease: inflammatory mediators
1Department of internal Medicine, University Hospital of Saarland, Homburg/Saar, Germany. josef.yayan@hotmail.com
Insights
Researchers identified 46 novel inflammation biomarkers for diagnosing coronary artery disease (CAD) and predicting acute coronary syndrome (ACS). This review highlights their potential to improve patient care and management.
Area of Science:
- Cardiology
- Biomarker Discovery
- Inflammation Research
Background:
- Inflammation plays a key role in atherosclerosis development in acute coronary syndrome (ACS) patients.
- C-reactive protein is a known prognostic inflammatory biomarker for ACS.
- Identifying novel circulating inflammatory biomarkers is crucial for diagnosing and predicting coronary artery disease (CAD).
Purpose of the Study:
- To identify novel circulating inflammatory biomarkers for diagnosing coronary artery disease (CAD).
Main Methods:
- A systematic literature search of the PubMed database was conducted for articles published between January 1, 2000, and June 30, 2012.
- Search terms included "infarction", "biomarkers", and "markers".
- Original articles in English describing clinical trials on novel inflammatory biomarkers for CAD were included.
Main Results:
- The search yielded 4,415 articles, with 53 biomarkers examined in the final review.
- 46 novel inflammation biomarkers were identified as useful for detecting coronary artery disease (CAD).
Conclusions:
- Novel biomarkers offer insights into the pathophysiology of CAD.
- Inflammatory biomarkers show significant potential for predicting ACS and recurrent ischemic events.
- These biomarkers may improve patient care and management strategies for cardiovascular disease.
Introduction:
Inflammation has been implicated in the development of atherosclerosis in patients with acute coronary syndrome. C-reactive protein is an established nonspecific prognostic inflammatory biomarker for patients with acute coronary syndrome in the medical literature. This has led to a concerted effort to identify circulating inflammatory biomarkers to facilitate predicting the risk for and diagnosing coronary artery disease in at-risk subjects. The objective of this study was to search after novel inflammatory biomarkers reported as useful for diagnosing coronary artery disease.
Methods:
The PubMed database was searched for reports published from January 1, 2000 to June 30, 2012 of novel circulating biomarkers for coronary artery disease in addition to the established biomarker, C-reactive protein. The search terms used were "infarction", "biomarkers", and "markers", and only original articles describing clinical trials that were written in English were included. All published articles were separately examined carefully after novel inflammatory markers for acute coronary syndrome. All irrelevant publications without content pertaining to inflammatory biomarkers for acute coronary syndrome were excluded from this study. Our results reflect all articles concerning biomarkers in humans.
Results:
The PubMed search yielded 4,415 research articles. After further analysis, all relevant published original articles examining 53 biomarkers were included in this review, which identified 46 inflammation biomarkers useful for detecting coronary artery disease.
Conclusion:
The emergence of diverse novel biomarkers for coronary artery disease has provided insight into the varied pathophysiology of this disease. Inflammatory biomarkers have tremendous potential in aiding the prediction of acute coronary syndrome and recurrent ischemic episodes, and will eventually help improve patient care and management.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease I: Introduction
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease II: Pathophysiology
Inflammation
Inflammation: Introduction

